 |
||
 |
Dendrimer |
Purchase Tickets Season Tickets for this event are available through our office at 503-232-2300 or online here! A season ticket represents a 40% savings off single ticket prices.
|
Donald Tomalia is a world-renowned leader in molecular research and the creator of dendrimers. He is Director of the National Dendrimer & Nanotechnology Center and Distinguished Professor/Research Scientist in the Department of Chemistry - Central Michigan University and external faculty at the University of Wisconsin (Madison)- School of Pharmacy. |
||
Dr.
Donald Dr. Donald Tomalia is the director of the National Dendrimer Center at Central Michigan University and a serial entrepreneur. During a long and successful career at Dow Chemical, his discovery of dendrimers (dentritic architecture) in 1979 led to his third R&D-100 Award in 1991 and the Leonardo da Vinci Award (Paris, France) in 1996. Dendritech, Inc., the first commercial producer of dendrimers, was co-founded by Dr. Tomalia in 1992, after which, he was named founding President and Chief Scientist (1992-2000). He became V.P. of Technology for MMI (1998-2000) while simultaneously serving as Scientific Director for the Biologic Nanotechnology Center, University of Michigan Medical School (1998-2000). Dr. Tomalia founded Dendritic Nanotechnologies, Inc. (DNT), Mt. Pleasant, Michigan, in a joint venture with Starpharma Pooled Development (Melbourne, Australia) (2002). Presently, he also serves as the DNT Principal Investigator in the Massachusetts Institute for Technology/Institute for Soldier Nanotechnologies (MIT/ISN) (2003). He is listed as the inventor of over 110 U.S. patents and is author/co-author of more than 200 peer-reviewed publications. |
As a result of their unique physico-chemical properties dendrimers are suitable for a wide range of novel biomedical and industrial uses. This new branch of supramolecular chemistry should spark new developments in both organic and macromolecular chemistry. Numerous applications of these compounds are conceivable, particularly in mimicking the functions of large biomolecules as drug carriers and immunogens.
|
|
